What are the diagnostic criteria and symptoms of iron overload?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Symptoms of Iron Overload

The diagnosis of iron overload should begin with serum transferrin saturation (>45%) and serum ferritin (>200 μg/L in women or >300 μg/L in men) measurements, followed by genetic testing for HFE mutations in suspected cases of hereditary hemochromatosis. 1

Diagnostic Approach

Laboratory Testing

  1. Initial screening tests:

    • Transferrin saturation (TS): >45% is suggestive of iron overload 1
    • Serum ferritin: >200 μg/L in women or >300 μg/L in men 1
  2. Confirmatory genetic testing:

    • Test for HFE gene mutations (C282Y and H63D) when iron overload is suspected 1
    • C282Y homozygosity or C282Y/H63D compound heterozygosity confirms hereditary hemochromatosis
  3. Additional laboratory assessment:

    • Liver function tests (elevated transaminases may indicate liver damage)
    • Ferritin/AST ratio can help predict tissue iron overload with high sensitivity (83.3%) and specificity (78.6%) 2

Imaging Studies

  • MRI with quantitative iron assessment: Non-invasive method to quantify iron deposition in liver and heart 1
  • Echocardiography: May show biventricular dilatation and restrictive cardiomyopathy in cardiac iron overload 1
  • Tissue Doppler imaging: Can detect early diastolic dysfunction before systolic dysfunction occurs 1

Tissue Biopsy

  • Liver biopsy: Gold standard for diagnosing liver iron overload 1
    • Perls' Prussian blue stain assesses iron distribution
    • Quantitative iron measurement by atomic absorption spectrometry
  • Myocardial biopsy: Less reliable due to patchy iron deposition in the heart 1

Clinical Symptoms and Signs

Asymptomatic Presentation

  • Many patients are identified through abnormal iron studies on routine screening or family screening 1
  • Patients should be evaluated for hemochromatosis even in the absence of symptoms if iron studies are abnormal 1

Systemic Symptoms

  • Weakness and lethargy: Present in 19-83% of patients 1
  • Fatigue: Common early symptom
  • Weight loss
  • Apathy

Organ-Specific Symptoms

  1. Liver manifestations:

    • Abdominal pain (0-58% of patients) 1
    • Hepatomegaly (3-83% of patients) 1
    • Elevated liver enzymes
    • Progressive fibrosis leading to cirrhosis (3-94% of patients depending on stage of diagnosis) 1
  2. Joint manifestations:

    • Arthralgias (13-57% of patients) 1
    • Arthritis, particularly in metacarpophalangeal joints
  3. Endocrine manifestations:

    • Diabetes (6-55% of patients) 1
    • Loss of libido and impotence (12-56% of patients) 1
    • Amenorrhea in women with cirrhosis 1
    • Testicular atrophy (14-50% of patients) 1
  4. Cardiac manifestations:

    • Congestive heart failure (0-35% of patients) 1
    • Arrhythmias
    • Early diastolic dysfunction detected by echocardiography 1
  5. Skin manifestations:

    • Hyperpigmentation (5-82% of patients) 1
    • Loss of body hair (6-32% of patients) 1

Important Clinical Considerations

  • Serum ferritin >1,000 ng/mL is associated with increased risk of hepatic fibrosis or cirrhosis 1
  • Ferritin can be elevated in inflammatory conditions without true iron overload, as it's an acute phase reactant 1
  • Cardiac iron deposition may occur despite normal serum ferritin levels 1
  • All patients with evidence of liver disease should be evaluated for hemochromatosis 1

Diagnostic Pitfalls to Avoid

  1. Relying solely on ferritin levels: Ferritin can be elevated in inflammation, infection, malignancy, and liver disease without true iron overload 1

  2. Missing hereditary hemochromatosis in patients with mild symptoms: Many patients present with nonspecific symptoms that can be overlooked

  3. Failing to screen family members: First-degree relatives of patients with hereditary hemochromatosis should be screened 1

  4. Overlooking secondary causes of iron overload: Consider hematologic disorders (thalassemia, myelodysplastic syndrome), chronic transfusions, and chronic liver diseases 3

  5. Delaying diagnosis until end-organ damage occurs: Cardiac involvement often develops late in the disease process when treatment may be less effective 1

Early diagnosis and treatment of iron overload are essential to prevent irreversible organ damage and improve mortality and quality of life outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Iron overload disorders.

Hepatology communications, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.